CBS 2019
CBSMD教育中心
English

动脉粥样硬化性心血管疾病

科研文章

荐读文献

Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel Effect of the PCSK9 Inhibitor Evolocumab on Total Cardiovascular Events in Patients With Cardiovascular DiseaseA Prespecified Analysis From the FOURIER Trial 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Association of White Matter Hyperintensities and Cardiovascular Disease: The Importance of Microcirculatory Disease The contribution of tissue-grouped BMI-associated gene sets to cardiometabolic-disease risk: a Mendelian randomization study Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT Coronary calcium as a predictor of coronary events in four racial or ethnic groups Myocardial bridging of the left anterior descending coronary artery is associated with reduced myocardial perfusion reserve: a 13N-ammonia PET study Association of Coronary Artery Calcium With Long-term, Cause-Specific Mortality Among Young Adults

Clinical Trial2011;364:818-28.

JOURNAL:N Engl J Med. Article Link

Long-term effects of intensive glucose lowering on cardiovascular outcomes

ACCORD Study Group, HC Gerstein, ME Miller et al. Keywords: T2DM; intensive glucose lowering; cardiovascular effect

Full Text PDF

网站资料更新中...